HSBC HOLDINGS PLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$958,464
-15.5%
26,975
+10.9%
0.00%0.0%
Q2 2023$1,133,962
+4.8%
24,313
-10.0%
0.00%0.0%
Q1 2023$1,082,172
-67.0%
27,012
-62.7%
0.00%
-75.0%
Q4 2022$3,277,891
+617.3%
72,480
+568.1%
0.00%
+300.0%
Q3 2022$457,000
-43.6%
10,849
-21.0%
0.00%0.0%
Q2 2022$810,000
-24.2%
13,733
-6.4%
0.00%0.0%
Q1 2022$1,069,000
+95.4%
14,668
+127.9%
0.00%0.0%
Q4 2021$547,000
-10.5%
6,437
-5.8%
0.00%0.0%
Q3 2021$611,000
-26.7%
6,834
-21.2%
0.00%0.0%
Q2 2021$833,000
+73.5%
8,672
+106.0%
0.00%0.0%
Q1 2021$480,000
-65.6%
4,209
-57.7%
0.00%
-50.0%
Q4 2020$1,397,000
+213.9%
9,962
+89.3%
0.00%
+100.0%
Q3 2020$445,000
-59.6%
5,263
-79.3%
0.00%
-50.0%
Q4 2019$1,102,000
-9.4%
25,424
-10.6%
0.00%0.0%
Q3 2019$1,217,000
+471.4%
28,448
+582.7%
0.00%
Q1 2018$213,000
-64.9%
4,167
-51.8%
0.00%
-100.0%
Q4 2016$607,000
+177.2%
8,645
+303.8%
0.00%
Q2 2015$219,0002,1410.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2023
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders